Informações:
Falhas:
ID
13485
Descrição
Randomized study with a run-in dose-selection phase to assess the added value of Lenalidomide in combination with standard remission-induction chemotherapy and post-remission treatment in patients aged 18-65 years with previously untreated acute myeloid leukemia (AML) or high risk myelodysplasia (MDS) (IPSS-R risk score> 4.5) Form Description: Second Randomization Form
Palavras-chave
Versões (3)
- 09/11/2015 09/11/2015 -
- 28/12/2015 28/12/2015 -
- 11/02/2016 11/02/2016 -
Transferido a
11 de fevereiro de 2016
DOI
Para um pedido faça login.
Licença
Creative Commons BY-NC 3.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Second Randomization Form HOVON 132 AML/SAKK 30/13 EudraCT 2013-002843-26
Second Randomization Form
- StudyEvent: ODM
Similar models
Second Randomization Form
- StudyEvent: ODM
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Caller
Item
Caller
text
C0557514 (UMLS CUI [1])
CL Item
post induction cycle III (3)
C3179010 (UMLS CUI-1)
CL Item
autoHSCT (4)
C0472699 (UMLS CUI-1)
Date start last treatment
Item
Date start last treatment
date
C0087111 (UMLS CUI [1,1])
C0808070 (UMLS CUI [1,2])
C0808070 (UMLS CUI [1,2])
CL Item
no CR(i) (0)
C3844738 (UMLS CUI-1)
CL Item
CR (1)
C0677874 (UMLS CUI-1)
CL Item
CRi (2)
C3538993 (UMLS CUI-1)
Neutrophil count
Item
ANC
float
C0948762 (UMLS CUI [1])
Platelets
Item
Platelets
float
C0005821 (UMLS CUI [1])
Creatinine Clearance
Item
Serum Creatinine Clearance
float
C0373595 (UMLS CUI [1])
Bilirubin
Item
Total bilirubin
float
C0201913 (UMLS CUI [1])
Bilirubin, Total ULN
Item
Bilirubin ULN
float
C0201913 (UMLS CUI [1,1])
C1519815 (UMLS CUI [1,2])
C1519815 (UMLS CUI [1,2])
AST
Item
AST
float
C0201899 (UMLS CUI [1])
AST ULN
Item
AST (SGOT) ULN
float
C0201899 (UMLS CUI [1,1])
C1519815 (UMLS CUI [1,2])
C1519815 (UMLS CUI [1,2])
ALT
Item
ALT
float
C0201836 (UMLS CUI [1])
ALT ULN
Item
ALT ULN
float
C0201836 (UMLS CUI [1,1])
C1519815 (UMLS CUI [1,2])
C1519815 (UMLS CUI [1,2])
Severe cardiac dysfunction
Item
Severe cardiac dysfunction (see appendix G)
boolean
C0009488 (UMLS CUI [1,1])
C0018801 (UMLS CUI [1,2])
C0018801 (UMLS CUI [1,2])
Severe pulmonary dysfunction
Item
Severe pulmonary dysfunction (see appendix F)
boolean
C0009488 (UMLS CUI [1,1])
C1709770 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
C1709770 (UMLS CUI [1,2])
C0205082 (UMLS CUI [1,3])
Severe neurological or psychiatric disease
Item
Severe neurological or psychiatric disease
boolean
C0009488 (UMLS CUI [1,1])
C0027765 (UMLS CUI [1,2])
C0027765 (UMLS CUI [1,2])
Active infections
Item
Serious active infections
boolean
C0009488 (UMLS CUI [1,1])
C3714514 (UMLS CUI [1,2])
C3714514 (UMLS CUI [1,2])
Item
Previous serious toxicities related to the use of lenalidomide
integer
C0020517 (UMLS CUI [1,1])
C1144149 (UMLS CUI [1,2])
C1144149 (UMLS CUI [1,2])
Code List
Previous serious toxicities related to the use of lenalidomide
CL Item
no (0)
C1298908 (UMLS CUI-1)
CL Item
yes (1)
C1705108 (UMLS CUI-1)
CL Item
NA (2)
CMV reactivation, which is not responsive to first line valganciclovir
Item
CMV reactivation, which is not responsive to first line valganciclovir
boolean
C0582172 (UMLS CUI [1,1])
C1142560 (UMLS CUI [1,2])
C0909381 (UMLS CUI [1,3])
C1142560 (UMLS CUI [1,2])
C0909381 (UMLS CUI [1,3])
Date of Randomization
Item
Date of Randomization
date
C0034656 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
C0011008 (UMLS CUI [1,2])
CL Item
Arm A: Observation only (1)
C0009932 (UMLS CUI-1)
CL Item
Arm B: Maintenance with Lenalidomide (2)
C0304231 (UMLS CUI-1)
C1144149 (UMLS CUI-2)
C1144149 (UMLS CUI-2)